The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs
Annual Scientific Meeting & Clinical Lab Expo 2022
Dr. Kim Kuypers will be speaking at the Annual Scientific Meeting & Clinical Lab Expo 2022 in Chicago on Monday July 25. Her talk will focus on the effects of psychedelics in full hallucinogenic doses and microdoses on human cognitive performance, empathy and wellbeing: implications for therapeutic applications. The session will consist of three speakers… Continue reading Annual Scientific Meeting & Clinical Lab Expo 2022
Scopolamine vs biperiden as cognitive deficit models: from animal to human research
In a recent review paper by professor Arjan Blokland, the effects of scopolamine and biperiden (and pirenzepine) are compared in animal studies and related to findings in humans. Scopolamine is used as a golden standard to induce memory impairments in animals and man. It has been used to validate new drugs for dementia-related disorders. However,… Continue reading Scopolamine vs biperiden as cognitive deficit models: from animal to human research
The history and current state of psychedelic research in the Netherlands
Curious about the history and current state of psychedelic research in the Netherlands? Prof Jan Ramaekers gives an overview at our most recent symposium. https://www.youtube.com/watch?v=K1EUyp7Zn-g&list=PL_BEhasNvGp86FDLoWvOh01YxcYnLlWT6&index=1
A comparison of acute neurocognitive and psychotomimetic effects of a synthetic cannabinoid and natural cannabis at psychotropic dose equivalence
Since about 20 years, smoking mixtures, such as Spice or K2, have become popular alternatives for cannabis. These smoking mixtures contain synthetic cannabinoids, which are reported to cause more psychological problems and stronger behavioral impairment. However, comparing the effects of synthetic cannabinoids with natural cannabis has been problematic due to the differences in pharmacological properties… Continue reading A comparison of acute neurocognitive and psychotomimetic effects of a synthetic cannabinoid and natural cannabis at psychotropic dose equivalence
Research day May 2022
It is with great joy that we post some of the photos take on the May 2022 edition of the Neuropsychology and Psychopharmacology Research Day. The event was a great opportunity to showcase all the research lines that are being pursued by each team, to exchange ideas in an open and welcoming atmosphere, to meet… Continue reading Research day May 2022